The 4 references without contexts in paper D. Romodanovsky P., D. Goryachev V., Д. Ромодановский П., Д. Горячев В. (2018) “Планирование и оценка исследований биоэквивалентности препаратов розувастатина // Planning and evaluation of bioequivalence studies of rosuvastatin drug products” / spz:neicon:vedomostincesmp:y:2017:i:3:p:142-149

4
The Federal Law of the Russian Federation of 22.12.2014 No. 429-FZ «On Amendments to the Federal Law «On Circulation of Medicines». Available from: https://goo.gl/sUorrH (in Russian).
(check this in PDF content)
5
The Federal Law of the Russian Federation of 13.07.2015 No. 241-FZ «On Amendments to the Federal Law «On Circulation of Medicines» and the Federal Law «On Amendments to the Federal Law «On Circulation of Medicines». Available from: https://goo.gl/ vNC34n (in Russian).
(check this in PDF content)
18
Guidance on evaluation of medicines. V. I. Moscow: Grif i K; 2013 (in Russian).
(check this in PDF content)
19
Rules for bioequivalence studies of drugs of the Eurasian Economic Union. Available from: https://goo.gl/j5Kunj (in Russian). AUTHORS Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation, Petrovsky boulevard 8, bld. 2, Moscow 127051, Russian Federation.
(check this in PDF content)